Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

NCT00005884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Non-melanomatous Skin Cancer

Interventions

DRUG: eflornithine

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]